Cargando…

COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?

Detalles Bibliográficos
Autores principales: Aubignat, M., Godefroy, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205702/
https://www.ncbi.nlm.nih.gov/pubmed/32409176
http://dx.doi.org/10.1016/j.neurol.2020.05.001
_version_ 1783530286696366080
author Aubignat, M.
Godefroy, O.
author_facet Aubignat, M.
Godefroy, O.
author_sort Aubignat, M.
collection PubMed
description
format Online
Article
Text
id pubmed-7205702
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-72057022020-05-08 COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies? Aubignat, M. Godefroy, O. Rev Neurol (Paris) Article Elsevier Masson SAS. 2020-06 2020-05-08 /pmc/articles/PMC7205702/ /pubmed/32409176 http://dx.doi.org/10.1016/j.neurol.2020.05.001 Text en © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Aubignat, M.
Godefroy, O.
COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
title COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
title_full COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
title_fullStr COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
title_full_unstemmed COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
title_short COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
title_sort covid-19 and ischemic stroke: should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205702/
https://www.ncbi.nlm.nih.gov/pubmed/32409176
http://dx.doi.org/10.1016/j.neurol.2020.05.001
work_keys_str_mv AT aubignatm covid19andischemicstrokeshouldwesystematicallylookforlupusanticoagulantandantiphospholipidantibodies
AT godefroyo covid19andischemicstrokeshouldwesystematicallylookforlupusanticoagulantandantiphospholipidantibodies